Form 4 for ISRG Intuitive Surgical
Accepted 2023-04-24 00:00:00 ET · period of report 2023-04-21 · accession 0001035267-23-000094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-04-24 | 2023-04-21 | ISRG | Curet Myriam | EVP, Chief Medical Off | S - Sale+OE | $299.76 | -9,623 | 1,950 | -83% | -$2.88M |
| DM | 2023-04-24 | 2023-04-21 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $172.35 | +8,000 | 3,950 | New | +$1.38M |
| DM | 2023-04-24 | 2023-04-21 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $0.00 | -8,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-21 | S | D | 505 | $300.00 | 327 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-21 | S | D | 1,118 | $297.92 | 832 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.54 to $299.27 as follows: 232 shares sold at $296.54 - $297.32; 666 shares sold at $297.57 - $298.50; 220 shares sold at $298.62 - $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2023-04-21 | S | D | 6,000 | $300.00 | 1,950 | D | — | — | |
| 4 | Common | Common Stock | 2023-04-21 | M | A | 6,000 | $174.26 | 7,950 | D | — | — | |
| 5 | Common | Common Stock | 2023-04-21 | M | A | 2,000 | $166.62 | 3,950 | D | — | — | |
| 6 | Common | Common Stock | 2023-04-21 | S | D | 2,000 | $300.00 | 1,950 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-04-21 | M | D | 2,000 | $0.00 | 4,500 | D | $166.62 · — to 2029-08-15 | 2,000 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-04-21 | M | D | 6,000 | $0.00 | 0 | D | $174.26 · — to 2028-08-15 | 6,000 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |